ID NRX2B_HUMAN Reviewed; 666 AA. AC P58401; DT 16-NOV-2001, integrated into UniProtKB/Swiss-Prot. DT 16-NOV-2001, sequence version 1. DT 24-JAN-2024, entry version 161. DE RecName: Full=Neurexin-2-beta; DE AltName: Full=Neurexin II-beta; DE Flags: Precursor; GN Name=NRXN2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16554811; DOI=10.1038/nature04632; RA Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., RA Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., RA Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G., RA Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C., RA Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A., RA Hattori M., Rogers J., Lander E.S., Sakaki Y.; RT "Human chromosome 11 DNA sequence and analysis including novel gene RT identification."; RL Nature 440:497-500(2006). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 90-666. RA Rowen L., Madan A., Qin S., Baradarani L., Birditt B., Bloom S., Burke J., RA Dors M., Fleetwood P., Kaur A., Madan A., Nesbitt R., Pate D., Hood L.; RT "Sequencing of human neurexin II gene."; RL Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Neuronal cell surface protein that may be involved in cell CC recognition and cell adhesion. CC -!- SUBUNIT: Interacts (via cytoplasmic C-terminal region) with CASK (By CC similarity). Specific isoforms bind alpha-dystroglycan and neuroligins CC NLGN1, NLGN2 and NLGN3 (By similarity). Interacts with CBLN1, CBLN2 CC and, less avidly, with CBLN4 (By similarity). Interacts with CLSTN3 (By CC similarity). {ECO:0000250|UniProtKB:E9Q7X7, CC ECO:0000250|UniProtKB:Q63376}. CC -!- SUBCELLULAR LOCATION: Presynaptic cell membrane {ECO:0000305}; Single- CC pass type I membrane protein {ECO:0000255}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative promoter usage, Alternative splicing; Named isoforms=3; CC Comment=A number of isoforms, alpha-type and beta-type are produced CC by alternative promoter usage. Beta-type isoforms differ from alpha- CC type isoforms in their N-terminus. Additional isoforms produced by CC alternative splicing seem to exist.; CC Name=1b; CC IsoId=P58401-1; Sequence=Displayed; CC Name=1a; CC IsoId=Q9P2S2-1; Sequence=External; CC Name=2a; Synonyms=Alpha-2B; CC IsoId=Q9P2S2-2; Sequence=External; CC -!- DOMAIN: Alternative splicing in the laminin G-like domain regulates CC binding to alpha-dystroglycan. CC -!- PTM: O-glycosylated; contains heparan sulfate. Heparan sulfate CC attachment is required for synapse development by mediating CC interactions with neuroligins. {ECO:0000250|UniProtKB:E9PUN2}. CC -!- SIMILARITY: Belongs to the neurexin family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AP001092; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC044790; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS8078.1; -. [P58401-1] DR RefSeq; NP_620063.1; NM_138734.2. [P58401-1] DR PDB; 4NXR; X-ray; 1.90 A; B=659-666. DR PDBsum; 4NXR; -. DR AlphaFoldDB; P58401; -. DR SMR; P58401; -. DR BioGRID; 114780; 6. DR IntAct; P58401; 1. DR MINT; P58401; -. DR GlyCosmos; P58401; 1 site, No reported glycans. DR BioMuta; NRXN2; -. DR DMDM; 17368287; -. DR MassIVE; P58401; -. DR PeptideAtlas; P58401; -. DR ProteomicsDB; 57072; -. [P58401-1] DR TopDownProteomics; P58401-1; -. [P58401-1] DR Antibodypedia; 63686; 62 antibodies from 7 providers. DR DNASU; 9379; -. DR Ensembl; ENST00000301894.6; ENSP00000301894.2; ENSG00000110076.21. [P58401-1] DR GeneID; 9379; -. DR UCSC; uc001oap.3; human. [P58401-1] DR AGR; HGNC:8009; -. DR CTD; 9379; -. DR DisGeNET; 9379; -. DR GeneCards; NRXN2; -. DR HGNC; HGNC:8009; NRXN2. DR HPA; ENSG00000110076; Tissue enriched (brain). DR MIM; 600566; gene. DR neXtProt; NX_P58401; -. DR OpenTargets; ENSG00000110076; -. DR PharmGKB; PA31787; -. DR VEuPathDB; HostDB:ENSG00000110076; -. DR GeneTree; ENSGT00940000155978; -. DR HOGENOM; CLU_025785_2_0_1; -. DR OrthoDB; 2999458at2759; -. DR PathwayCommons; P58401; -. DR Reactome; R-HSA-6794361; Neurexins and neuroligins. DR SignaLink; P58401; -. DR SIGNOR; P58401; -. DR BioGRID-ORCS; 9379; 16 hits in 1149 CRISPR screens. DR ChiTaRS; NRXN2; human. DR GeneWiki; NRXN2; -. DR GenomeRNAi; 9379; -. DR Pharos; P58401; Tbio. DR Proteomes; UP000005640; Chromosome 11. DR Bgee; ENSG00000110076; Expressed in right hemisphere of cerebellum and 139 other cell types or tissues. DR ExpressionAtlas; P58401; baseline and differential. DR GO; GO:0042995; C:cell projection; IEA:UniProtKB-KW. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-SubCell. DR GO; GO:0050839; F:cell adhesion molecule binding; TAS:BHF-UCL. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0097109; F:neuroligin family protein binding; TAS:BHF-UCL. DR GO; GO:0004888; F:transmembrane signaling receptor activity; NAS:BHF-UCL. DR GO; GO:0007158; P:neuron cell-cell adhesion; TAS:BHF-UCL. DR GO; GO:0007165; P:signal transduction; NAS:BHF-UCL. DR CDD; cd00110; LamG; 1. DR Gene3D; 2.60.120.200; -; 1. DR InterPro; IPR013320; ConA-like_dom_sf. DR InterPro; IPR001791; Laminin_G. DR InterPro; IPR003585; Neurexin-like. DR PANTHER; PTHR15036:SF52; NEUREXIN-2; 1. DR PANTHER; PTHR15036; PIKACHURIN-LIKE PROTEIN; 1. DR Pfam; PF02210; Laminin_G_2; 1. DR SMART; SM00294; 4.1m; 1. DR SMART; SM00282; LamG; 1. DR SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 1. DR PROSITE; PS50025; LAM_G_DOMAIN; 1. DR Genevisible; P58401; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative promoter usage; Alternative splicing; Calcium; KW Cell adhesion; Cell membrane; Cell projection; Glycoprotein; KW Heparan sulfate; Membrane; Metal-binding; Proteoglycan; Reference proteome; KW Repeat; Signal; Synapse; Transmembrane; Transmembrane helix. FT SIGNAL 1..50 FT /evidence="ECO:0000250|UniProtKB:Q63376" FT CHAIN 51..666 FT /note="Neurexin-2-beta" FT /id="PRO_0000019497" FT TOPO_DOM 51..590 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 591..611 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 612..666 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 91..299 FT /note="Laminin G-like" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00122" FT REGION 1..30 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 327..346 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 412..443 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 479..580 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 633..666 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 529..555 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 650..666 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 143 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:Q63373" FT BINDING 160 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:Q63373" FT BINDING 242 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:Q63373" FT BINDING 244 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000250|UniProtKB:Q63373" FT CARBOHYD 190 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 354 FT /note="O-linked (Xyl...) (heparan sulfate) serine" FT /evidence="ECO:0000250|UniProtKB:E9PUN2" FT STRAND 660..665 FT /evidence="ECO:0007829|PDB:4NXR" SQ SEQUENCE 666 AA; 70927 MW; FD0B2FD353F63C6C CRC64; MPPGGSGPGG CPRRPPALAG PLPPPPPPPP PPLLPLLPLL LLLLLGAAEG ARVSSSLSTT HHVHHFHSKH GTVPIAINRM PFLTRGGHAG TTYIFGKGGA LITYTWPPND RPSTRMDRLA VGFSTHQRSA VLVRVDSASG LGDYLQLHID QGTVGVIFNV GTDDITIDEP NAIVSDGKYH VVRFTRSGGN ATLQVDSWPV NERYPAGNFD NERLAIARQR IPYRLGRVVD EWLLDKGRQL TIFNSQAAIK IGGRDQGRPF QGQVSGLYYN GLKVLALAAE SDPNVRTEGH LRLVGEGPSV LLSAETTATT LLADMATTIM ETTTTMATTT TRRGRSPTLR DSTTQNTDDL LVASAECPSD DEDLEECEPS TGGELILPII TEDSLDPPPV ATRSPFVPPP PTFYPFLTGV GATQDTLPPP AARRPPSGGP CQAERDDSDC EEPIEASGFA SGEVFDSSLP PTDDEDFYTT FPLVTDRTTL LSPRKPAPRP NLRTDGATGA PGVLFAPSAP APNLPAGKMN HRDPLQPLLE NPPLGPGAPT SFEPRRPPPL RPGVTSAPGF PHLPTANPTG PGERGPPGAV EVIRESSSTT GMVVGIVAAA ALCILILLYA MYKYRNRDEG SYQVDQSRNY ISNSAQSNGA VVKEKAPAAP KTPSKAKKNK DKEYYV //